01:38 PM EDT, 09/07/2022 (MT Newswires) -- Imara (IMRA) said it agreed to sell IMR-687, also known as tovinontrine, and all other assets related to its PDE9 program to Cardurion Pharmaceuticals.
Shares surged 64% by Wednesday afternoon as intraday trading volume soared to more than 82.8 million compared with its daily average of roughly 60,000.
Sidus Space (SIDU) said it signed a launch agreement with SpaceX for five launches of Sidus' LizzieSat satellites starting early next year.
The company expects the launches to support previously disclosed contracts with NASA and Mission Helios.
Shares jumped 27% amid an increase in intraday trading volume to over 28.2 million versus its daily average of about 6.33 million.
Glaukos (GKOS) reported topline data from two phase-3 pivotal trials of iDose TR achieved their primary efficacy endpoints through three months and demonstrated excellent tolerability and a favorable safety profile through 12 months.
Shares climbed 24% after intraday trading volume surged to over 2.58 million versus its daily average of about 457,000.